T

The Movement Disorder Clinic of Oklahoma | Tulsa, OK

Research site
(Unclaimed)
Location
7134 S Yale Avenue, Suite 205, Tulsa, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

ABBV-951
Carbidopa
Levodopa
APL-130277
PF-06649751
Prasinezumab
RO7486967
Apokyn
IPX066
K0706

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 22 total trials

A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

This is a phase 2 study designed to assess the safety, tolerability and efficacy of NLY01 in subjects with early untreated Parkinson's disease (PD)....

Active, not recruiting
Parkinson Disease
Drug: NLY01
Drug: Vehicle

This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a...

Active, not recruiting
Parkinson's Disease
Drug: ND0612

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab...

Active, not recruiting
Parkinsons Disease
Drug: Prasinezumab
Drug: Placebo

This multicenter, randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy of intravenous prasinezumab (RO7046015/PRX00...

Active, not recruiting
Parkinson's Disease
Drug: RO7046015
Drug: Placebo

This is a multi-center, randomized, double blind, adaptive, parallel-group, placebo controlled Phase 1b study to evaluate the safety, tolerability, p...

Enrolling
Parkinson Disease
Drug: RO7486967
Drug: Placebo

This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to...

Active, not recruiting
Early Parkinson Disease
Other: placebo
Drug: K0706

This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy

Active, not recruiting
Multiple System Atrophy
Drug: ATH434 dose level 2
Drug: ATH434 dose level 1

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting
Parkinson's Disease (PD)
Drug: ABBV-951

Trial sponsors

AbbVie logo
Roche logo
Sumitomo Pharma logo
I
Pfizer logo
A
E
I
I
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems